Drug
Milnacipran
Milnacipran: highest development phase Phase 2, developed by Pierre Fabre. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Pierre Fabre
Trials
| Drug | Phase | Indication |
|---|---|---|
| Milnacipran NCT00757679 | Phase 2 | Fibromyalgia Syndrome |
Latest
No recent events.
Follow Milnacipran on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.